Year: 2026
Type: article
Study design: Observational Study
Abstract: Background and Objectives UBTF encodes the upstream binding transcription factor (UBTF), a protein essential for rRNA synthesis. Dominantly acting pathogenic variants, either de novo or inherited, have been associated with a broad clinical childhood-onset neurodegenerative/neurodevelopmental spectrum whose genotype-phenotype correlation has not been accurately defined yet. This multicenter study aims to conduct a retrospective analysis of a large cohort of patients with pathogenic variants in the UBTF gene to refine diagnostic criteria and identify clinically relevant outcome measures for future trials. Methods Clinical centers provided clinical, molecular, and neuroimaging data on patients carrying pathogenic or predicted pathogenic UBTF variants, consistent with the clinical phenotype. Data were collected using an human phenotype ontology–based standardized electronic case report form and included unreported cases or updated information on patients reported in the literature from January 2017 to December 2024. Results A cohort of 49 patients (23 previously unreported) was included in the study. The disease typically presented at ≤3 years (89.6%) with neuroregression in 71.4% of cases, either in a child with preexisting neurodevelopmental delay (42.9%) or after previously normal psychomotor development (28.6%). Less frequently, neurodevelopmental delay occurred in isolation (26.5%). During disease progression, patients developed behavioral abnormalities (81.6%), movement disorders (78.3%), autonomic manifestations (50.0%), and epilepsy (34.7%). At the last follow-up (mean age 13 years and 6 months), only 2 patients were deceased (4.1%). The main neuroimaging findings included white matter hyperintensity (68.1%), cerebral (66.0%) and cerebellar (51.1%) atrophy, and thinning of the corpus callosum (38.3%). However, brain MRI findings were reported as normal in 21.3% of cases. We identified 7 novel UBTF variants (c.271G>C; c.349A>T; c.495C>A; c.517G>A; c.761A>G; c.1048-2A>G; and c.1625_1626+15del). Genotype-phenotype analysis led to the distinction of 2 allelic, clinically distinct disorders: a childhood-onset neurodegenerative disease due to gain-of-function variants, characterized by the triad of neuroregression, movement, and behavioral disorders, and a neurodevelopmental disorder with a milder clinical course associated with loss-of-function/hypomorphic variants. Discussion The results from our deep-phenotyping analysis suggest the classification of UBTF -related disease into 2 main clinical syndromes impacting the natural history of the disease with a different degree of severity and complexity. This novel observation should be considered in the management and prognosis of patients and will be fundamental in the design of targeted therapies.
Source: Neurology Genetics
Authors: Giulia Balletto, Sara Carli, Antonietta Coppola, Annalaura Torella, Hsiu-Fen Lee, Christoph Korenke, Sebastien Lebon, Lucie Sedlackova, Amanda Nagy, Florian S. Eichler, Chaya N. Murali, Vincenzo Nigro, Farah Alnoor Ladha, Mark S. Ledoux, Silvia Pelle, Giulia Prato, Lino Nobili, Luigi Chiriatti, Cecilia Mancini, Giuseppe Zampino, Claudio Graziano, Kristin Baranano, Pauline Planté-Bordeneuve, Roseline Caumes, Barbora Lauerová, Jana Haberlová, Duccio Maria Cordelli, Chiara Fiorillo, Marco Tartaglia, Rory James Tinker, Caterina Garone
Institutions: Istituto Giannina Gaslini, University of Genoa, University of Bologna, Federico II University Hospital, University of Campania "Luigi Vanvitelli", National Chung Hsing University, Taichung Veterans General Hospital, Klinikum Oldenburg, Centre Hospitalier Universitaire Vaudois, Charles University, Fakultní nemocnice Motol a Homolka, Massachusetts General Hospital, Baylor College of Medicine, Texas Children's Hospital, University of Memphis, Bambino Gesù Children's Hospital, Agostino Gemelli University Polyclinic, Azienda Unità Sanitaria Locale Della Romagna, Johns Hopkins University, Johns Hopkins Medicine, Centre Hospitalier Universitaire de Lille, University Hospital in Motol, Istituto delle Scienze Neurologiche di Bologna, Icahn School of Medicine at Mount Sinai
Language: English
Subfield: Genetics
Domain: Life Sciences
Keywords: UBTF, neurodevelopmental disorders, neurodegeneration, genotype-phenotype correlation, pathogenic variants, novel variants, neuroregression, white matter hyperintensities, brain atrophy, corpus callosum thinning, epilepsy, movement disorders, behavioral abnormalities, gain-of-function mutations, loss-of-function mutations, ribosomal RNA synthesis, diagnostic criteria
Open Access status: gold
Estimated APC paid: $3,300
OpenAlex ID: W7225627283
